Massimo Gadina

Massimo Gadina

Company: NIAMS/NIH

Job title: Director & Chief of Translational Immunology Section, Science & Technology

Seminars:

An Overview of JAKi in Rheumotology 9:50 am

Historical overview of how JAK inhibitors were developed. Review of first-generation pan-JAK inhibitors and their current clinical application JAK-selective, second-generation JAK inhibitors: what is there already and what is arriving. The effect of JAK inhibitors on circulating immune cellRead more

day: Day One

Chair’s closing remarks 6:00 pm

Read more

day: Day One

Speaker Q&A panel 10:25 am

Read more

day: Day One

Chair’s Opening Remarks 8:50 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.